183 related articles for article (PubMed ID: 23077535)
1. Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
Tian J; Ma J; Ma K; Ma B; Tang X; Baidoo SE; Tong J; Yan J; Lu L; Xu H; Wang S
PLoS One; 2012; 7(10):e46936. PubMed ID: 23077535
[TBL] [Abstract][Full Text] [Related]
2. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.
Tian J; Ma J; Wang S; Yan J; Chen J; Tong J; Wu C; Liu Y; Ma B; Mao C; Jiao Z; Shao Q; Lu L; Xu H
Cell Immunol; 2011; 270(2):183-7. PubMed ID: 21636079
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma.
Ma J; Wang S; Ma B; Mao C; Tong J; Yang M; Wu C; Jiao Z; Lu L; Xu H
Cancer Lett; 2011 Feb; 301(2):142-50. PubMed ID: 21186078
[TBL] [Abstract][Full Text] [Related]
5. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
[TBL] [Abstract][Full Text] [Related]
6. TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation.
Ni XY; Sui HX; Liu Y; Ke SZ; Wang YN; Gao FG
Oncol Rep; 2012 Aug; 28(2):615-21. PubMed ID: 22614805
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose LPS Induces Tolerogenic Treg Skewing in Asthma.
Ding F; Liu B; Niu C; Wang T; Wang Y; Geng G; Tian D; Dai J; Fu Z
Front Immunol; 2020; 11():2150. PubMed ID: 33072079
[TBL] [Abstract][Full Text] [Related]
8. Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.
Li B; Cai Y; Qi C; Hansen R; Ding C; Mitchell TC; Yan J
Clin Cancer Res; 2010 Nov; 16(21):5153-64. PubMed ID: 20855461
[TBL] [Abstract][Full Text] [Related]
9. Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells.
Tuyaerts S; Van Meirvenne S; Bonehill A; Heirman C; Corthals J; Waldmann H; Breckpot K; Thielemans K; Aerts JL
J Leukoc Biol; 2007 Jul; 82(1):93-105. PubMed ID: 17449724
[TBL] [Abstract][Full Text] [Related]
10. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism.
Carmona EM; Vassallo R; Vuk-Pavlovic Z; Standing JE; Kottom TJ; Limper AH
J Immunol; 2006 Jul; 177(1):459-67. PubMed ID: 16785543
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.
Piao J; Kamimura Y; Iwai H; Cao Y; Kikuchi K; Hashiguchi M; Masunaga T; Jiang H; Tamura K; Sakaguchi S; Azuma M
Immunology; 2009 Aug; 127(4):489-99. PubMed ID: 19604302
[TBL] [Abstract][Full Text] [Related]
13. Simultaneously increased expression of glucocorticoid‑induced tumor necrosis factor receptor and its ligand contributes to increased interleukin‑5/13‑producing group 2 innate lymphocytes in murine asthma.
Zhang M; Wan J; Xu Y; Zhang D; Peng J; Qi C; Guo Q; Xia S; Su Z; Wang S; Xu H
Mol Med Rep; 2017 Jun; 15(6):4291-4299. PubMed ID: 28440511
[TBL] [Abstract][Full Text] [Related]
14. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
15. Biological role of GITR/GITRL in attributes and immune responses of macrophage.
Fu Z; Wang S; Li J; Zhang Y; Li H; Li G; Wan X; Zhang Y
J Leukoc Biol; 2020 Feb; 107(2):309-321. PubMed ID: 31833599
[TBL] [Abstract][Full Text] [Related]
16. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
[TBL] [Abstract][Full Text] [Related]
17. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
[TBL] [Abstract][Full Text] [Related]
18. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
Richards DM; Marschall V; Billian-Frey K; Heinonen K; Merz C; Redondo Müller M; Sefrin JP; Schröder M; Sykora J; Fricke H; Hill O; Gieffers C; Thiemann M
J Immunother Cancer; 2019 Jul; 7(1):191. PubMed ID: 31324216
[TBL] [Abstract][Full Text] [Related]
19. Role of the glucocorticoid-induced TNFR-related protein (GITR)-GITR ligand pathway in innate and adaptive immunity.
Azuma M
Crit Rev Immunol; 2010; 30(6):547-57. PubMed ID: 21175417
[TBL] [Abstract][Full Text] [Related]
20. The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells.
Wang C; Zhou Q; Wang X; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2015 Jan; 6(3):1779-89. PubMed ID: 25593198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
